Second primary cancers following radiotherapy for prostate cancer: How many are actually due to the radiotherapy?
作者信息
Morgan Scott C, Corkum Mark T
机构信息
Department of Radiology, Radiation Oncology and Medical Physics, University of Ottawa, Ottawa, ON, Canada.
出版信息
Can Urol Assoc J. 2024 Apr;18(4):129-130. doi: 10.5489/cuaj.8760.
Abstract
摘要
相似文献
1
Second primary cancers following radiotherapy for prostate cancer: How many are actually due to the radiotherapy?前列腺癌放疗后的第二原发性癌症：究竟有多少是由放疗引起的？
Can Urol Assoc J. 2024 Apr;18(4):129-130. doi: 10.5489/cuaj.8760.
2
Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.局部前列腺癌碳离子放疗、光子放疗或手术治疗后的继发原发性癌症风险：一项倾向评分加权的回顾性队列研究。
Lancet Oncol. 2019 May;20(5):674-685. doi: 10.1016/S1470-2045(18)30931-8. Epub 2019 Mar 15.
3
Is there an increased risk of second primaries following prostate irradiation?前列腺放疗后发生第二原发性肿瘤的风险会增加吗？
Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):251-5. doi: 10.1016/s0360-3016(97)00570-1.
4
Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?前列腺癌放疗后的继发性癌症：我们是否应更加关注其风险？
Eur Urol. 2007 Oct;52(4):973-82. doi: 10.1016/j.eururo.2007.07.002. Epub 2007 Jul 10.
5
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.前列腺癌放疗后的第二原发性恶性肿瘤：系统评价与荟萃分析。
BMJ. 2016 Mar 2;352:i851. doi: 10.1136/bmj.i851.
6
Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.前列腺癌放疗后发生第二原发性癌症的风险：一项基于人群的分析。
Radiat Oncol. 2017 Jan 3;12(1):2. doi: 10.1186/s13014-016-0738-z.
7
Assessment of Second Primary Cancer Risk Among Men Receiving Primary Radiotherapy vs Surgery for the Treatment of Prostate Cancer.接受前列腺癌根治性放疗与根治性手术治疗的男性患者中第二原发癌风险评估。
JAMA Netw Open. 2022 Jul 1;5(7):e2223025. doi: 10.1001/jamanetworkopen.2022.23025.
8
Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.早期前列腺癌现代外照射放疗所致放射性第二原发癌风险：立体定向消融放疗（SABR）、容积调强弧形放疗（VMAT）及无均整器放疗（FFF）的影响
Phys Med Biol. 2015 Feb 7;60(3):1237-57. doi: 10.1088/0031-9155/60/3/1237. Epub 2015 Jan 15.
9
Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.盆腔放疗后肌层浸润性膀胱癌预后是否更差？一项基于 SEER 的研究。
Cancer Treat Res Commun. 2020;24:100177. doi: 10.1016/j.ctarc.2020.100177. Epub 2020 May 24.
10
[Two cases of second bladder cancer after radiotherapy for prostate cancer].[前列腺癌放疗后发生第二原发性膀胱癌2例]
Nihon Hinyokika Gakkai Zasshi. 2005 Mar;96(3):466-9. doi: 10.5980/jpnjurol1989.96.466.
本文引用的文献
1
Incidence and survival of secondary malignancies after external beam radiotherapy for prostate cancer in the SEER database.SEER数据库中前列腺癌外照射放疗后继发性恶性肿瘤的发病率和生存率。
Can Urol Assoc J. 2024 Apr;18(4):121-128. doi: 10.5489/cuaj.8508.
2
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.前列腺癌监测、手术或放疗后 15 年的结果。
N Engl J Med. 2023 Apr 27;388(17):1547-1558. doi: 10.1056/NEJMoa2214122. Epub 2023 Mar 11.
3
Association between body mass index and localized prostate cancer management and disease-specific quality of life.体重指数与局限性前列腺癌管理及疾病特异性生活质量之间的关联。
BJUI Compass. 2022 Nov 2;4(2):223-233. doi: 10.1002/bco2.197. eCollection 2023 Mar.
4
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.辅助或早期挽救性放疗治疗局限性和局部进展性前列腺癌：汇总数据的前瞻性计划系统评价和荟萃分析。
Lancet. 2020 Oct 31;396(10260):1422-1431. doi: 10.1016/S0140-6736(20)31952-8. Epub 2020 Sep 28.
5
Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data.辨别接受根治性前列腺切除术或放疗的前列腺癌患者的生存优势：癌症登记数据的局限性。
Cancer. 2017 May 1;123(9):1617-1624. doi: 10.1002/cncr.30506. Epub 2017 Jan 18.
6
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.前列腺癌放疗后的第二原发性恶性肿瘤：系统评价与荟萃分析。
BMJ. 2016 Mar 2;352:i851. doi: 10.1136/bmj.i851.
7
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.霍奇金淋巴瘤治疗后 40 年内的二次癌症风险。
N Engl J Med. 2015 Dec 24;373(26):2499-511. doi: 10.1056/NEJMoa1505949.
8
Smoking and prostate cancer survival and recurrence.吸烟与前列腺癌的生存和复发。
JAMA. 2011 Jun 22;305(24):2548-55. doi: 10.1001/jama.2011.879.
9
Cancer incidence after localized therapy for prostate cancer.前列腺癌局部治疗后的癌症发病率。
Cancer. 2006 Sep 1;107(5):991-8. doi: 10.1002/cncr.22083.
Zotero 插件